DK0451834T3 - alfa-Mannosidase- og fucosidase-hæmmere - Google Patents

alfa-Mannosidase- og fucosidase-hæmmere

Info

Publication number
DK0451834T3
DK0451834T3 DK91105766.9T DK91105766T DK0451834T3 DK 0451834 T3 DK0451834 T3 DK 0451834T3 DK 91105766 T DK91105766 T DK 91105766T DK 0451834 T3 DK0451834 T3 DK 0451834T3
Authority
DK
Denmark
Prior art keywords
alpha
mannosidase
fucosidase inhibitors
beta
fucosidase
Prior art date
Application number
DK91105766.9T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Robert A Farr
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0451834T3 publication Critical patent/DK0451834T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91105766.9T 1990-04-12 1991-04-11 alfa-Mannosidase- og fucosidase-hæmmere DK0451834T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (1)

Publication Number Publication Date
DK0451834T3 true DK0451834T3 (da) 1996-08-26

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91105766.9T DK0451834T3 (da) 1990-04-12 1991-04-11 alfa-Mannosidase- og fucosidase-hæmmere

Country Status (19)

Country Link
EP (1) EP0451834B1 (cs)
JP (1) JP2955057B2 (cs)
KR (1) KR100197382B1 (cs)
CN (1) CN1033638C (cs)
AT (1) ATE140692T1 (cs)
AU (1) AU646855B2 (cs)
CA (1) CA2040058C (cs)
DE (1) DE69121000T2 (cs)
DK (1) DK0451834T3 (cs)
ES (1) ES2092520T3 (cs)
FI (1) FI109200B (cs)
GR (1) GR3020934T3 (cs)
HU (1) HU213396B (cs)
IE (1) IE75195B1 (cs)
IL (1) IL97814A (cs)
NO (1) NO175856C (cs)
NZ (1) NZ237734A (cs)
PT (1) PT97339B (cs)
ZA (1) ZA912588B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US6051711A (en) * 1997-10-24 2000-04-18 Glycodesign Inc. Synthesis of swainsonine salts
WO2011094536A1 (en) * 2010-01-28 2011-08-04 Raptor Pharmaceuticalls Inc. Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
HU911196D0 (en) 1991-10-28
DE69121000T2 (de) 1996-12-19
HUT60994A (en) 1992-11-30
IL97814A (en) 1995-08-31
IE911229A1 (en) 1991-10-23
CA2040058C (en) 2001-10-23
GR3020934T3 (en) 1996-12-31
ATE140692T1 (de) 1996-08-15
AU7416491A (en) 1991-10-17
NO175856B (cs) 1994-09-12
IL97814A0 (en) 1992-06-21
NO911419D0 (no) 1991-04-11
ES2092520T3 (es) 1996-12-01
HU213396B (en) 1997-06-30
KR910018341A (ko) 1991-11-30
EP0451834B1 (en) 1996-07-24
JPH04234834A (ja) 1992-08-24
AU646855B2 (en) 1994-03-10
CN1033638C (zh) 1996-12-25
NO911419L (no) 1991-10-14
NZ237734A (en) 1993-05-26
ZA912588B (en) 1992-01-29
EP0451834A3 (en) 1993-10-20
EP0451834A2 (en) 1991-10-16
CN1055732A (zh) 1991-10-30
JP2955057B2 (ja) 1999-10-04
PT97339B (pt) 1998-08-31
NO175856C (no) 1994-12-21
CA2040058A1 (en) 1991-10-13
FI911751A0 (fi) 1991-04-11
FI911751L (fi) 1991-10-13
FI109200B (fi) 2002-06-14
KR100197382B1 (ko) 1999-06-15
DE69121000D1 (de) 1996-08-29
PT97339A (pt) 1992-01-31
IE75195B1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ATE226201T1 (de) Substituierte pyridylpyrazole
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
FI910017A0 (fi) Haeftkugghjulsaggregat med perforerande utspraong foer anvaendning i en konverter avsedd att producera kuddliknande daempningsmaterial och foerfarande.
FI873812A0 (fi) Foerfarande och anordning i en torkningsgrupp med enkel vira foer pappersmaskin.
DE69001081D1 (de) Laserbohrer.
FI923171A0 (fi) Elektrodloes konduktivitetsgivare med uppblaosbar yta.
ES2022686B3 (es) Protesis total de la rodilla.
FI880429L (fi) Foerfarande foer utbredning av ett eldfast skikt med hjaelp av sprutning pao en yta och ett pao detta saett bildat skikt.
BR8700486A (pt) Conjunto de resfriamento passivo
DE69121000D1 (de) Alpha-Mannosidase- und fucosidase-Hemmer
FI880213A0 (fi) System och foerfarande foer att foelja med vaottemperaturen i en roekgasstroem.
FI851142A0 (fi) Superledare med foerbaettrade icke-resis- tiva egenskaper.
IT1247591B (it) Metodo ed utensile per la digitalizzazione di maschere di foratura.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
EP0641327A4 (en) Novel alpha-mannosidase inhibitors.
ITMI910319A0 (it) Processo di dealogenazione di 1,3-diossolani
DE3779675D1 (de) 6-(disubstituiertes amino)carbapenam-verbindungen.
DE69003790D1 (de) Arbeitsmittel.
IT8848548A0 (it) Procedimento per il post-trattamento di substrati tinti, stampati o foulardati
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
ES1014709Y (es) Disposicion perfeccionada de centros de mecanizado.
ATE74348T1 (de) Lipoxygenase-inhibitor verbindungen.
FI891635A0 (fi) Med reflekterande yta foersett trafikstyrningsdon.
NO881907D0 (no) Dyse for laserbehandling.